share_log

InterCure Ltd. (NASDAQ:INCR) Sees Significant Decline in Short Interest

InterCure Ltd. (NASDAQ:INCR) Sees Significant Decline in Short Interest

InterCure有限公司(纳斯达克代码:INCR)认为空头股数的销量大幅下降
Defense World ·  2022/08/17 04:51

InterCure Ltd. (NASDAQ:INCR – Get Rating) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 79,600 shares, a drop of 6.9% from the July 15th total of 85,500 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 55,400 shares, the days-to-cover ratio is currently 1.4 days.

InterCure Ltd.(纳斯达克评级:INCR-GET)看到空头股数在7月份出现了显著下降。截至7月31日,空头股数共有79,600股,较7月15日的85,500股下降了6.9%。该公司约0.3%的股票被卖空。以日均成交量55,400股计算,目前天数与回补比率为1.4天。

InterCure Stock Down 3.2 %

InterCure股价下跌3.2%

INCR stock opened at $6.02 on Wednesday. The firm has a market cap of $257.26 million and a PE ratio of 50.17. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.26 and a current ratio of 1.67. The firm's fifty day moving average is $6.00 and its 200 day moving average is $6.37. InterCure has a one year low of $5.42 and a one year high of $8.77.

周三,INCR的股票开盘报6.02美元。该公司市值为2.5726亿美元,市盈率为50.17倍。该公司的负债权益比率为0.07,速动比率为1.26,流动比率为1.67。该公司的50日移动均线切入位为6.00美元,200日移动均线切入位为6.37美元。InterCure的一年低点为5.42美元,一年高位为8.77美元。

Get
到达
InterCure
InterCure
alerts:
警报:

InterCure (NASDAQ:INCR – Get Rating) last released its quarterly earnings results on Monday, May 16th. The company reported $0.11 EPS for the quarter. The company had revenue of $27.29 million for the quarter. InterCure had a net margin of 5.38% and a return on equity of 3.23%.

InterCure(纳斯达克:INCR-GET评级)最近一次发布季度收益报告是在5月16日(星期一)。该公司公布本季度每股收益为0.11美元。该公司本季度的收入为2729万美元。InterCure的净利润率为5.38%,股本回报率为3.23%。

Institutional Trading of InterCure

InterCure的机构交易

Institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC lifted its stake in shares of InterCure by 70.4% in the second quarter. Citadel Advisors LLC now owns 25,661 shares of the company's stock worth $149,000 after buying an additional 10,598 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of InterCure by 756.0% in the second quarter. JPMorgan Chase & Co. now owns 6,309 shares of the company's stock worth $37,000 after buying an additional 5,572 shares in the last quarter. Citigroup Inc. lifted its stake in shares of InterCure by 9,567.9% in the first quarter. Citigroup Inc. now owns 5,124 shares of the company's stock worth $36,000 after buying an additional 5,071 shares in the last quarter. Davy Global Fund Management Ltd purchased a new position in shares of InterCure in the first quarter worth about $152,000. Finally, ETF Managers Group LLC purchased a new position in InterCure during the fourth quarter worth about $3,592,000. Institutional investors and hedge funds own 9.34% of the company's stock.
机构投资者最近调整了对该股的持有量。Citadel Advisors LLC在第二季度增持了70.4%的InterCure股票。Citadel Advisors LLC现在持有该公司25,661股股票,价值149,000美元,上个季度又购买了10,598股。摩根大通在第二季度增持了756.0%的InterCure股票。摩根大通在上个季度又购买了5,572股,目前持有6,309股该公司股票,价值37,000美元。花旗集团(Citigroup Inc.)在第一季度增持了9,567.9%的InterCure股票。花旗集团(Citigroup Inc.)在上个季度增持了5,071股后,目前持有5,124股该公司股票,价值36,000美元。Davy Global Fund Management Ltd在第一季度购买了InterCure的新头寸,价值约15.2万美元。最后,ETF Manager Group LLC在第四季度购买了InterCure的一个新头寸,价值约3,592,000美元。机构投资者和对冲基金持有该公司9.34%的股票。

About InterCure

关于InterCure

(Get Rating)

(获取评级)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.

InterCure有限公司及其子公司在以色列和国际上从事医用大麻产品的研究、种植、生产、营销和分销。它提供干燥的大麻花序和混合了油的大麻提取物。该公司还投资于BioMed部门。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on InterCure (INCR)
  • Are These 3 Video Game Stocks Now In Play?
  • 2 Long-Term EV Plays Trading Under $20
  • Why Apple is Primed to Take a Bite Out of Live Sports
  • Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
  • Home Depot Results Point To Sluggish 2nd Half
  • 免费获取StockNews.com关于InterCure的研究报告(INCR)
  • 这3只电子游戏股票现在还在玩吗?
  • 2辆长期电动汽车的交易价格低于20美元
  • 苹果为何准备退出体育直播
  • 埃克森美孚和西方石油导致内幕人士本月大量买入
  • 家得宝业绩指向低迷的下半年

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.

接受InterCure Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对InterCure和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发